Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Cook Medical Starts China Trial of Drug Eluting Stent for PAD

publication date: Aug 18, 2014
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Cook Medical, a privately held US medical device maker, has begun enrolling patients in a China clinical trial of its Zilver® PTX® Drug Eluting Peripheral Stent. The stent is seeking China approval as a treatment for peripheral arterial disease (PAD) in above-the-knee arteries between 4 mm and 9 mm in diameter. Cook Medical makes an extensive variety of medical products including catheters, wire guides and stents for use in surgical and minimally invasive procedures. More details.....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
ChinaBio Leadership Retreat 2014
Suzhou, China
October 23-24, 2014
 
China Forum 2014

Frankfurt, Germany
November 2, 2014

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors